Immune reconstitution after allogeneic hematopoietic stem cell transplantation and analysis of risk factors for acute graft-versus-host disease
沈耀耀,刘跃均,吴德沛,陈佳,徐杨,薛胜利,周海侠,李晓莉,朱明清
DOI: https://doi.org/10.3760/cma.j.issn.1009-9921.2015.06.006
2015-01-01
Abstract:Objective To investigate the relationship between the reconstitution of lymphocyte subsets after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and acute graft-versus-host disease (aGVHD),and to explore the risk factors of aGVHD.Methods The proportions of peripheral blood lymphocyte subsets of 65 patients undergoing allo-HSCT during Jan 2012 and Nov 2013 were retrospectively analyzed.The lymphocyte subsets proportion in peripheral blood lymphocyte was studied by flow cytometry on 1st,3rd,6th and 12nd month after transplantation,respectively.The risk factors of aGVHD were analyzed by Logistic regression.Results The proportion of CD3+ T subsets of the peripheral blood lymphocyte in patients who accepted allo-HSCT was decreased obviously since implantation.The proportion of CD3+ T subsets on 1st month after transplantation was decreased significantly,then gradually rose to normal [(63.65±6.64) ％] on 3rd month after transplantation.Among them,the proportion of CD3+ CD4+ T subsets was lowest on 1st month after transplantation and was reconstructed slowly to normal until 12nd month after transplantation [(23.94 ± 3.15) ％].Proportion of CD3+ CD8+ T subsets was decreased and rose to normal [(31.06±8.40)％] on 1st month after transplantation.CD3+ CD4+ and CD3+ CD8+ ratio was at a low level after transplantation,and still lower than normal at 12nd month after a slow recovery,which was approximately 0.54±0.11.The proportion of CD3+ CD25+ was low on 1st month [(2.16±0.93)％] and was increased to normal at 3rd month.Proportion of CD3-CD16+ CD56+ cells was increased significantly to (42.31±8.47) ％,and gradually fallen down to normal at 6th month.In the first 3 months after implantation,CD3+ T cells from patients with aGVHD (grade Ⅲ-Ⅳ) significantly were increased comparing with patients without aGVHD (1 month:P =0.037,3 months:P =0.045) as well as CD3+ CD25+ T cells (1 month:P =0.025,3 months:P =0.041),which was opposite to CD3+ CD4+/CD3+ CD8+ (1 month:P =0.040,3 months:P =0.043).On 1st month after transplantation,CD3+ CD4+ T cells from patients without aGVHD displayed higher than that from patients with aGVHD (grade Ⅲ-Ⅳ) (P =0.032) as well as CD3-CD16+ CD56+ cells (P =0.046),which was opposite to CD3+ CD8+ cells (P =0.029).The results of multivariate analysis showed that donor-recipient HLA mismatching (OR =2.511,P =0.024),unrelated donor (OR =2.964,P =0.018) and GVHD prophylaxis without ATG (OR =2.792,P =0.033) were the risk factors for aGVHD.Conclusion Our results support the utility of post-transplant monitoring of a peripheral blood lymphocyte subset for early warning aGVHD of patients undergoing allo-HSCT.Donorrecipient HLA mismatching,unrelated donor and GVHD prophylaxis without ATG are the risk factors for aGVHD.